Short-Acting Benzos vs Long-Acting Benzos

Benzodiazepines (benzos) are central nervous system (CNS) depressants that can relieve anxiety and muscle spasms, reduce seizures, and produce hypnosis and sedation. These prescription drugs are available in short-acting and long-acting forms.1

The two types of benzos affect your body for different time periods and can treat various conditions based on your needs.1 Read on to learn more about short vs long-acting benzos and how to get started on recovery at our addiction treatment center in Kansas City.

What Are Short-Acting Benzodiazepines

Short-acting benzodiazepines are depressants with different uses, including inducing sedation and treating insomnia, and other conditions.1 These drugs are designed to act quickly, producing rapid relief.2

Common short-acting benzodiazepines include alprazolam (Xanax), triazolam (Halcion), midazolam (Versed), and oxazepam (Serax).1,2

How Do Short-Acting Benzos Work?

Short-acting benzos work to calm or sedate you by boosting GABA, a chemical that helps slow brain activity.3 Many short-acting benzodiazepines produce rapid effects because they are absorbed quickly, which may contribute to greater misuse potential.2

Many short-acting benzodiazepines have an average elimination half-life of up to 12 hours.2 A drug’s half-life is the amount of time it takes for its concentration in your body to fall to half of its original level.4 Substances with longer half-lives can take more time to metabolize in your body.4

Short-acting benzos, such as midazolam, are rapidly absorbed into the bloodstream and enter the brain almost immediately. This short half-life means the body also metabolizes it quickly. That said, its effects are short-lived and clear from the body fast.2

What Are Long-Acting Benzodiazepines?

Long-acting benzos are depressants with a longer duration of action. Generally used to treat anxiety, insomnia, and panic attacks, other brands of these drugs can also be used to prevent seizures.1,2

Common long-acting benzodiazepines include diazepam (Valium), clonazepam (Klonopin), clorazepate (Tranxene), chlordiazepoxide (Librium), and flurazepam (Dalmane). These medications remain active in the body longer because they have longer elimination half-lives and, in some cases, produce active metabolites that extend their effects.1,2

How Do Long-Acting Benzos Work?

Long-acting benzodiazepines remain in the body longer because they have longer elimination half-lives and, in some cases, active metabolites. These drugs are of low to moderate strength with a half-life of between 40 and 250 hours.2

Each long-acting benzodiazepine may metabolize differently in the body, but they generally remain in your system longer and work for an extended period. For example, diazepam creates and breaks down active metabolites in the body, which makes its effects last considerably longer than short-acting benzos.2

Immediate-Acting Benzodiazepines

Some benzodiazepines do not fit neatly into either the short-acting or long-acting categories. These medications are often classified as intermediate-acting benzodiazepines because their elimination half-lives and durations of action fall between the two. Like all benzodiazepines, they enhance the effects of gamma-aminobutyric acid (GABA), helping slow activity in the brain to produce calming, anti-anxiety, sedative, and muscle-relaxing effects.2,3

Common intermediate-acting benzodiazepines include lorazepam (Ativan), temazepam (Restoril), and estazolam (ProSom).² These medications are prescribed for a variety of conditions depending on the specific drug. For example, lorazepam is commonly used to treat anxiety disorders, while temazepam and estazolam are primarily prescribed for the short-term treatment of insomnia.1,2

Intermediate-acting benzodiazepines generally have a moderate duration of action, remaining active in the body longer than short-acting benzodiazepines but not as long as long-acting medications. Because of this balance, healthcare providers may prescribe them when a medication with an intermediate duration of action is appropriate for a patient’s symptoms and treatment goals.²

Short-Acting vs Long-Acting Benzodiazepines

While short-acting and long-acting benzodiazepines belong to the same drug class, there are clear differences between the two. From uses to withdrawal symptoms, here are the key features that set them apart:

• Uses: Both forms can treat similar conditions, like anxiety, insomnia, and seizures. However, short-acting benzos are often prescribed to manage acute symptoms while long-acting ones typically treat ongoing symptoms.1,2
• How they work: Both short-acting and long-acting benzodiazepines increase GABA in the brain, but short-acting benzos are absorbed and cleared quickly, producing fast effects. Long-acting benzos stay in the body longer, resulting in prolonged effects.2,3
• Length of action: Short-acting benzos act quickly and wear off fast, making them effective for sudden or acute symptoms. Long-acting benzodiazepines remain active in the body longer, providing effects that last longer than short-acting agents.2
• Withdrawal symptoms: While similar withdrawal symptoms appear when stopping the use of either form, short-acting benzos produce more intense symptoms. Withdrawal symptoms for long-acting benzodiazepines are often less intense but last longer.5
• Risk of addiction: Addiction is a possibility with either form of benzodiazepine. Still, due to their rapid onset and short duration, short-acting benzos have a higher risk of dependence and substance use disorder (SUD).2,6

Benzodiazepine Addiction and Withdrawal

Long-term use can lead to dependence or addiction, regardless of the type of benzo.7 Withdrawal symptoms typically develop when you discontinue use.2 Benzo withdrawal symptoms can be dangerous, so it’s important to seek medical withdrawal management services to reach stabilization safely.5

Medical professionals often provide a tapering strategy, where you gradually decrease benzo use over time to prevent serious complications, like withdrawal seizures.5 Even after quitting benzos, withdrawal symptoms can persist long-term for some.8 Here are some common benzo withdrawal symptoms:9

• Impaired cognitive functioning (i.e., memory loss, impaired concentration)
• Anxiety
• Pain, burning, or aches
• Blurred vision
• Muscle spasms
• Digestive problems
• Seizures
• Hallucinations

Benzodiazepine Post-Acute Withdrawal Syndrome (PAWS)

Post-Acute Withdrawal Syndrome (PAWS) refers to a group of persistent symptoms present after initial withdrawal.8 Some experience these symptoms for months to years after quitting benzos.8 Here’s what someone with PAWS might experience:9

• Anxiety
• Sleep disturbances
• Impaired cognition
• Low energy
• Sense sensitivity
• Impaired memory
• Digestive problems
• Seizures
• Pain, burning, or aches

Benzo Addiction Treatment and Recovery in Kansas City

If you or a loved one is struggling with benzo addiction, treatment is available at Empowered Recovery Kansas City. Our treatment center offers several levels of addiction treatment to meet you where you are in recovery.

You can access partial hospitalization programs (PHPs), intensive outpatient programs (IOPs), and standard outpatient care. We also offer specialized approaches, including medication-assisted treatment (MAT). We work with you to create a personalized treatment plan that prioritizes your needs and recovery goals.

Our admissions team guides you through the process and can answer any questions about starting rehab in Kansas City. We can help you explore programs and ways to cover the cost of rehab, including using rehab insurance coverage. Contact Empowered Recovery Kansas City to verify your insurance coverage and begin your recovery journey.

References

1. U.S. Drug Enforcement Administration. (2024). Benzodiazepines. Retrieved on January 15, 2026, from https://www.dea.gov/sites/default/files/2025-01/Benzodiazepines-2024-Drug-Fact-Sheet.pdf
2. Griffin, C., Kaye, A., Bueno, F., & Kaye, A. (2013). Benzodiazepine pharmacology and central nervous system-mediated effects. Retrieved on January 15, 2026, from https://pmc.ncbi.nlm.nih.gov/articles/PMC3684331/
3. National Institute on Drug Abuse. (2022). Benzodiazepines and Opioids. Retrieved on January 15, 2026, from https://nida.nih.gov/research-topics/opioids/benzodiazepines-opioids
4. Hallare, J., Gerriets, V. (2025). Elimination Half-Life of Drugs. Retrieved on January 15, 2026, from https://www.ncbi.nlm.nih.gov/books/NBK554498/
5. Health Research Board. (n.d.). HRB National Drugs Library: Benzodiazepines. Retrieved on January 15, 2026, from https://www.drugsandalcohol.ie/glossary/info/benzodiazepines#:~:text=Long%2Dacting%20benzodiazepines%20include%20diazepam,(see%20Multiple%20drug%20use)
6. Hallfors, D., & Saxe, L. (1993). The dependence potential of short half-life benzodiazepines: a meta-analysis. Retrieved on January 15, 2026, from https://pubmed.ncbi.nlm.nih.gov/8103297/
7. U.S. Food and Drug Administration. (2020). FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class. Retrieved on January 15, 2026, from https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class
8. Haskell, B. (2022). Identification and Evidence-Based Treatment of Post–Acute Withdrawal Syndrome. Retrieved on January 15, 2026, from https://www.sciencedirect.com/science/article/abs/pii/S1555415521005523#preview-section-references
9. Huff, C., Finlayson, A., Foster, D., & Martin, P. (2023). Enduring neurological sequelae of benzodiazepine use: an Internet survey. Retrieved on January 15, 2026, from https://pmc.ncbi.nlm.nih.gov/articles/PMC9905027/#section8-20451253221145561